Hank McKinnell Quotations

We are providing choice, simplicity and expanded access to help Americans get the medicines they need,

On any given day, we estimate that nearly 40 million people around the world are treated with a Pfizer medicine,

Revenues in the third quarter of 2005 reflected lower prescription growth and increased competition in key therapeutic markets in the U.S., such as the lipid-lowering market, where the rate of growth in the third quarter declined significantly versus the first half of the year; and the erectile dysfunction market, which has been in decline compared to 2004.

Based on today's survey, we see job growth and continued investment, a winning combination at this part of the business cycle.

Frankly, there are lots of other places in the company to trim expenses before you would turn to the sales force.

Going into 2006, America's CEOs believe that the economy will remain resilient despite the challenges of several unanticipated events.

Lipitor is one of the most important medical breakthroughs of our era, and millions of patients have used it to lower their cholesterol. This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them.

There has to be a balanced approach, which first satisfies our need for security and at the same time makes sure we allow reasonable access to foreign investors to the United States.

We are evaluating our financial prospects in light of current and anticipated business conditions and are withdrawing our prior guidance.

We are evaluating our financial prospects for 2006 and 2007 in light of current and anticipated business conditions and are withdrawing our prior guidance for those years,

You are seeing business confidence increasing to the point where people are willing to add permanent jobs to the payroll as opposed to trying to fill that need through additional overtime.

What analysts are coming to understand is that comparisons to last year are particularly difficult in the second quarter, ... And what I am sure they will soon understand is that comparisons are particularly easy in the fourth quarter and that makes our estimate of $1.56 to $1.60 (per share for 2002) fully achievable.

We are supporting our key in-line and newly launched medicines, driving important new medicines through the pipeline and taking a series of specific actions to build Pfizer's value.

Quite frankly, with the two companies together we can get more out of the pipeline than we could separately.

Our drug looks like it can take the quit rate up to 50 percent,

as close to zero as you can get.

This is a normal part of our planning cycle, ... You should have as much confidence in us this week as you had last week.

This is a time of transformation for Pfizer and our industry. We are responding directly to the realities of our operating environment as we build value today while aggressively investing in the future.

This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them,

They had been putting the same percentage increase on each quarter, and in an unusually low quarter like last year that didn't' work, ... So we directed them to take down their second-quarter estimates through our guidance.

It looks like a combination of raising HDL and lowering LDL cholesterol could have dramatic impact, maybe eliminating cardiovascular risk,

In each of the three areas of this survey -- sales, capital spending and employment -- more companies still anticipate expansion rather than contraction. Capital expenditure plans continue to reflect steady gains, and employment predictions by the nation's leading companies are near their all-time high.

In addition to our financial contribution and product donations, we are ensuring that Pfizer colleagues with the needed medical and technical skills are available to assist with the relief effort.

By transferring their expertise to local healthcare workers, these Fellows make lasting contributions to support health systems in communities ravaged by diseases. The Pfizer Global Health Fellows program represents an innovative collaboration between NGOs and the private sector to significantly improve the lives of people around the world in a sustainable way.

This is a healthy rate of growth. So 3.3 percent into 2006 ... represents a continuing strong economy.